Integrin α5β1 simultaneously controls EGFR-dependent proliferation and Akt-dependent pro-survival signaling in epidermoid carcinoma cells

Aging

Volumn 4, Issue 5, 2012, Pages 368-374

  Morozevich, Galina E ^a   Kozlova, Nadezda I ^a   Ushakova, Natalia A ^a   Preobrazhenskaya, Marina E ^a   Berman, Albert E ^a  

^a INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

Author keywords

Apoptosis; EGFR; Integrins; proliferation; Signal transduction

Indexed keywords

EGFR PROTEIN, HUMAN; EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEIN KINASE B; VERY LATE ACTIVATION ANTIGEN 5;

ARTICLE; CELL PROLIFERATION; DOWN REGULATION; HUMAN; METABOLISM; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE;

CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; HUMANS; INTEGRIN ALPHA5BETA1; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION;

EID: 84867451757     PISSN: 19454589     EISSN: None     Source Type: Journal    
DOI: 10.18632/aging.100457     Document Type: Article

References (27)

1. Weber GL, Parat MO, Binder ZA, Gallia GL, Riggins GJ. Abrogation of PIK3CA or PIK3R1 reduces proliferation, migration, and invasion in glioblastoma multiforme cells. Oncotarget 2011; 2:833-849.
2. Soung YH, Clifford JL, Chung CJ. Crosstalk between integrin and receptor tyrosine kinase signaling in breast carcinoma progression. BMB reports 2010; 43: 311-318.
3. Zhang Z, Stiegler AL, Boggon TJ, Kobayashi S, Halmos B. EGFRmutated lung cancer: a paradigm of molecular oncology. Oncotarget 2010; 1:497-514.
4. Chappell WH, Steelman LS, Long JM, Kempf RC, Abrams SL, Franklin RA, Bäsecke J, Stivala F, Donia M, Fagone P, Malaponte G, Mazzarino MC, et al. Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR inhibitors: rationale and importance to inhibiting these pathways in human health. Oncotarget 2011; 2:135-164.
5. Hynes RO. Integrins: bidirectional, allosteric signaling machines. Cell 2002; 110: 673-687.
6. Kuwada SK, Kuang J, Li X. Integrin alpha5/beta1 expression mediates HER-2 down-regulation in colon cancer cells. J. Biol. Chem. 2005; 280: 19027-19035.
7. Samandari E, Visarius T, Zingg JM, Azzi A. The effect of gamma-tocopherol on proliferation, integrin expression, adhesion, and migration of human glioma cells. Biochem. Biophys. Res. Comun. 2006; 342: 1329-1333.
8. Rohwer N, Welzel M, Daskalow K, Pfander D, Wiedenmann B, Detjen K, Cramer T. Hypoxia-inducible factor 1alpha mediates anoikis resistance via suppression of alpha5 integrin. Cancer Res. 2008; 68: 10113-10120.
9. Proulx S, Guérin SL, Salesse C. Effect of quiescence on integrin alpha5beta1 expression in human retinal pigment epithelium. Mol. Vis.2003; 9: 473-481.
10. Liu D, Aguirre Ghiso J, Estrada Y, Ossowski L. EGFR is a transducer of the urokinase receptor initiated signal that is required for in vivo growth of a human carcinoma. Cancer Cell 2002; 5:445-457.
11. Roovers K, Assoian RK. Integrating the MAP kinase signal into the G1 phase cell cycle machinery. Bioessays 2000; 22: 818-826.
12. Frisch SM, Screaton RA Anoikis mechanisms. Curr. Opin. Cell Biol. 2001; 13:555-562.
13. Haenssen KK, Caldwell SA, Shahriari KS, Jackson SR, Whelan KA, Klein-Szanto A.J, Reginato MJ. ErbB2 requires integrin alpha5 for anoikis resistance via Src regulation of receptor activity in human mammary epithelial cells. J. Cell Sci 2010; 123: 1373-1382.
14. Nimwegen MJ, Water B. Focal adhesion kinase: A potential target in cancer therapy. Biochemical Pharmacology 2007; 73: 597-609.
15. Mitra S K , Schlaepfer DD. Integrin-regulated FAK-Src signaling in normal and cancer cells. Curr? Opin. Cell Biol. 2006; 18: 516-523.
16. Morozevich GE, Kozlova NI, Cheglakov IB, Ushakova NA, Berman AE. Integrin a5ß1 controls invasion of human breast carcinoma cells bydirect and indirect modulation of MMP-2 collagenase activity. Cell Cycle 2009; 8: 2219-2225.
17. Sokolosky ML, Stadelman KM, Chappell WH, Abrams SL, Martelli AM, Stivala F, Libra M, Nicoletti F, Drobot LB, Franklin RA, Steelman LS, McCubrey JA. Involvement of Akt-1 and mTOR in sensitivity of breast cancer to targeted therapy. Oncotarget 2011; 2:538-550.
18. Hart JR, Vogt PK. Phosphorylation of AKT: a mutational analysis. Oncotarget 2011; 2:467-476.
19. Yamada KM, Even-Ram S. Integrin regulation of growth factor receptors . Nat. Cell Biol. 2002; 4: E75-76.
20. Bill HM, Knudsen B, Moores SL, Muthuswamy SK, Rao VR, Brugge JS, Miranti CK. Epidermal growth factor receptordependent regulation of integrin-mediated signaling and cell cycle entry in epithelial cells. Mol. Cell. Biol. 2004; 19: 8586-8599.
21. Zhang X, Groopman JE, Wang JF. Extracellular matrix regulates endothelial functions through interaction of VEGFR-3 and integrin alpha5beta1. J. Cell. Physiol. 2005; 202:205-214.
22. Liu J, DeYoung SM, Zhang Mi, Zhang, Me., Cheng A, Saltiel AR. Changes in integrin expression during adipocyte differentiation. Cell Metab. 2005; 2: 165-177.
23. Färber K, Synowitz M, Zahn G, Vossmeyer D, Stragies R, van Rooijen, Kettenmann H. An alpha5beta1 integrin inhibitor attenuates glioma growth. Mol. Cell. Neurosci. 2008; 39: 579-585.
24. Okazaki T, Ni A, Ayeni OA, Baluk P, Yao L.-C, Vossmeyer D, Zischinsky G, Zahn G, Knolle J, Christner C, McDonald DM. a5ß1 integrin blockade inhibits lymphangiogenesis in airway inflammation. Amer. J. Pathol. 2009; 174: 2378-2387.
25. Gilcrease MZ. Integrin signaling in epithelial cells. Cancer Letters 2007; 247: 1-25.
26. Schwartz MA, Ginsberg MH. Networks and crosstalk: integrin signalling spreads. Nat. Cell Biol. 2002; 4: E65-E68.
27. Kuwada SK, Li X. Integrin a5/b1 mediates fibronectindependent epithelial cell proliferation through epidermal growth factor receptor activation 2000; 11: 2485-2496.